[go: up one dir, main page]

PL3811967T3 - Wytwarzanie biologicznie aktywnych kompleksów - Google Patents

Wytwarzanie biologicznie aktywnych kompleksów

Info

Publication number
PL3811967T3
PL3811967T3 PL20208669.0T PL20208669T PL3811967T3 PL 3811967 T3 PL3811967 T3 PL 3811967T3 PL 20208669 T PL20208669 T PL 20208669T PL 3811967 T3 PL3811967 T3 PL 3811967T3
Authority
PL
Poland
Prior art keywords
preparation
biologically active
active complexes
complexes
biologically
Prior art date
Application number
PL20208669.0T
Other languages
English (en)
Inventor
Catharina Svanborg
Aftab NADEEM
Chin Shing HO
Original Assignee
Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamlet Pharma Ab filed Critical Hamlet Pharma Ab
Publication of PL3811967T3 publication Critical patent/PL3811967T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
PL20208669.0T 2017-05-14 2018-05-14 Wytwarzanie biologicznie aktywnych kompleksów PL3811967T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1707715.7A GB201707715D0 (en) 2017-05-14 2017-05-14 Preperation of biologically active complexes

Publications (1)

Publication Number Publication Date
PL3811967T3 true PL3811967T3 (pl) 2024-03-18

Family

ID=59201543

Family Applications (2)

Application Number Title Priority Date Filing Date
PL18729327T PL3618848T3 (pl) 2017-05-14 2018-05-14 Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne
PL20208669.0T PL3811967T3 (pl) 2017-05-14 2018-05-14 Wytwarzanie biologicznie aktywnych kompleksów

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL18729327T PL3618848T3 (pl) 2017-05-14 2018-05-14 Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne

Country Status (13)

Country Link
US (2) US20200140481A1 (pl)
EP (2) EP3618848B1 (pl)
JP (2) JP7672122B2 (pl)
KR (1) KR20200015557A (pl)
CN (2) CN119700935A (pl)
AU (1) AU2018269304B2 (pl)
CA (1) CA3063285A1 (pl)
DK (2) DK3618848T3 (pl)
ES (2) ES2973290T3 (pl)
FI (1) FI3811967T3 (pl)
GB (1) GB201707715D0 (pl)
PL (2) PL3618848T3 (pl)
WO (1) WO2018210759A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201621752D0 (en) * 2016-12-20 2017-02-01 Hamlet Pharma Ab Therapeutically active complexes
GB201707715D0 (en) 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes
GB2574845A (en) * 2018-06-20 2019-12-25 Hamlet Pharma Ab Therapeutically active complexes
WO2019243547A1 (en) * 2018-06-20 2019-12-26 Hamlet Pharma Ab Therapeutically active complexes
EP4017522A1 (en) * 2019-08-20 2022-06-29 HAMLET Pharma AB Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy
GB202015836D0 (en) * 2020-10-06 2020-11-18 Hamlet Pharma Ab Compositions
AU2023357946A1 (en) 2022-10-03 2025-04-24 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1871252A (zh) * 2003-09-05 2006-11-29 Gtc生物治疗学公司 在转基因哺乳动物奶中生产融合蛋白的方法
US8796218B2 (en) 2009-01-09 2014-08-05 Hamlet Pharma Ab Complex and production process
WO2010131237A1 (en) 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
GB0908279D0 (en) 2009-05-14 2009-06-24 Enovate Systems Ltd Subsea winch
EP2643010B1 (en) 2010-11-24 2016-11-16 HAMLET Pharma AB Biologically active complex and its preparation
PL2882446T3 (pl) 2012-08-09 2018-10-31 Hamlet Pharma Ab Terapia profilaktyczna i nutraceutyczna
GB201621752D0 (en) * 2016-12-20 2017-02-01 Hamlet Pharma Ab Therapeutically active complexes
GB201707715D0 (en) 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes

Also Published As

Publication number Publication date
KR20200015557A (ko) 2020-02-12
DK3811967T5 (da) 2024-08-19
US12331073B2 (en) 2025-06-17
JP7705160B2 (ja) 2025-07-09
JP7672122B2 (ja) 2025-05-07
EP3618848B1 (en) 2020-11-25
FI3811967T3 (fi) 2023-12-28
US20210130394A1 (en) 2021-05-06
CN110650746B (zh) 2024-12-31
CN110650746A (zh) 2020-01-03
GB201707715D0 (en) 2017-06-28
WO2018210759A1 (en) 2018-11-22
DK3618848T3 (da) 2021-03-01
AU2018269304A1 (en) 2019-11-21
EP3618848A1 (en) 2020-03-11
JP2023075290A (ja) 2023-05-30
AU2018269304B2 (en) 2025-02-27
CA3063285A1 (en) 2018-11-22
EP3811967B1 (en) 2023-12-20
ES2973290T3 (es) 2024-06-19
JP2020519673A (ja) 2020-07-02
US20200140481A1 (en) 2020-05-07
ES2861252T3 (es) 2021-10-06
PL3618848T3 (pl) 2021-06-14
CN119700935A (zh) 2025-03-28
EP3811967A1 (en) 2021-04-28
DK3811967T3 (da) 2024-01-08

Similar Documents

Publication Publication Date Title
PL3811967T3 (pl) Wytwarzanie biologicznie aktywnych kompleksów
IL275046A (en) History Phenylamidine kills microorganisms
ZA201805747B (en) Biologically active cannabidiol analogs
EP3722497A4 (en) FABRIC TREATMENT COMPOSITION
AP2017009773A0 (en) Encapsulation of hydrophobic biologically active compounds
IL253803B (en) A preparation for the treatment of hypothyroidism
IL269061A (en) A pharmaceutical preparation containing Selexifag
IL254398A0 (en) Antimicrobial compounds and methods for their preparation and use
GB201501793D0 (en) Encapsulation of high potency active agents
GB201813986D0 (en) Coffins
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
IL260766B (en) Continuous production of complexes containing active pharmaceutical ingredients
IL272857A (en) Cofanalisib formulations
IL268514A (en) Medical bacteriophage preparations
GB201621752D0 (en) Therapeutically active complexes
PT3582617T (pt) Formulação estável de piridazinpirazolamidas pesticidas
GB201909518D0 (en) 4-N-Butylresorcinol preparations
IL256486B1 (en) Formulations to improve the effectiveness of hydrophobic drugs
PL3381457T3 (pl) Fizjologicznie czynna kompozycja zawierająca n-acetyloglukozaminę do leczenia bólów pleców
PT3471702T (pt) Formulação termoestável de substâncias biologicamente ativas
PT3678644T (pt) Formulações de copanlisib
AU201711233S (en) Mobile patient bed
ZA201908255B (en) Treatment of oral candidiasis
ZA201805215B (en) Preparation for nasal-nasopharyngeal treatment
IL255374A0 (en) biological preparation